Dr. Walters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5717 Balcones Dr
Austin, TX 78731Phone+1 512-327-7000Fax+1 512-314-1662
Summary
- Dr. Thomas Walters is an ophthalmologist in Austin, TX. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 35 years. He specializes in lens refractive surgery, cataract surgery, refractive laser surgery, and comprehensive ophthalmology.
Education & Training
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Ophthalmology, 1983 - 1986- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Internship, Internal Medicine, 1982 - 1983
University of Texas Southwestern Medical SchoolClass of 1982
Certifications & Licensure
TX State Medical License 1983 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Lifetime Achievement Award American Academy of Ophthalmology, 2020
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 58 citations24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsE. Randy Craven, Thomas R Walters, William C. Christie, Douglas G. Day, Richard A. Lewis
Drugs. 2020-02-01 - 33 citationsBimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomis...Douglas G. Day, Thomas R Walters, Gail F. Schwartz, Thomas K Mundorf, Charlie Liu
The British Journal of Ophthalmology. 2013-08-01 - 64 citationsPhase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)Felipe A. Medeiros, Thomas R Walters, Miriam Kolko, Michael Coote, Marina Bejanian
Ophthalmology. 2020-06-13
Press Mentions
Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019May 6th, 2019
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase 2 Data Demonstrating 11-Month Duration-of-Action After a Single Dose in Patients with GlaucomaFebruary 3rd, 2017
iPad Screenings Effective for Detecting Early Signs of Glaucoma in Underserved, High-Risk PopulationsOctober 19th, 2014
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
